(Q38692706)

5 September 2017

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome (English)

1 reference

5 September 2017

1 reference

prostatic hypertrophy

1 reference

3

Mario Maggi

1 reference

5 September 2017

Linda Vignozzi

1

1 reference

5 September 2017

Mauro Gacci

series ordinal

2

1 reference

5 September 2017

language of work or name

English

0 references

publication date

12 January 2016

1 reference

5 September 2017

Nature Reviews Urology

1 reference

5 September 2017

13

1 reference

5 September 2017

2

1 reference

5 September 2017

108-119

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2015.301

5 September 2017

0 references

cites work

Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The current and future burden and cost of overactive bladder in five European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The International Continence Society “Benign Prostatic Hyperplasia” Study: The Bothersomeness of Urinary Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Prevalence, risk factors and the bother of lower urinary tract symptoms in China: a population-based survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Immune cell crosstalk in obesity: a key role for costimulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Non-alcoholic fatty liver disease, obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Macrophages, immunity, and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Causes of metabolic syndrome and obesity-related co-morbidities Part 1: A composite unifying theory review of human-specific co-adaptations to brain energy consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Testosterone and metabolic syndrome: a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Androgen regulation of prostate cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Obesity and late-onset hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Effects of obesity on lower urinary tract symptoms in Korean BPH patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Body mass index and risk of BPH: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Benign prostatic enlargement is not associated with diabetes: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome and prostate abnormalities in male subjects of infertile couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and International Prostate Symptom Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome associated with reduced lower urinary tract symptoms in middle-aged men receiving health checkup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower likelihood of having moderate-to-severe lower urinary tract symptoms in middle-aged healthy Korean men with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Body mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Criteria and classification of obesity in Japan and Asia-Oceania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Diabetes: Advances in Diagnosis and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower urinary tract symptoms in the danish population: a population-based study of symptom prevalence, health-care seeking behavior and prevalence of treatment in elderly males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Targeting inflammation in metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Benign prostatic hyperplasia: a new metabolic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Increased serum C-reactive protein level is associated with increased storage lower urinary tract symptoms in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association Between High-sensitivity C-reactive Protein and Lower Urinary Tract Symptoms in Healthy Korean Populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Neuroendocrine probes of serotonergic function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

A deficit in peripheral serotonin levels in major depressive disorder but not in chronic widespread pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower urinary tract symptoms and depressive symptoms in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower urinary tract symptoms and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Urinary incontinence and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower urinary tract symptoms, obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Are physical activity, smoking and alcohol consumption associated with lower urinary tract symptoms in men or women? Results from a population based observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Relationship between lifestyle and health factors and severe lower urinary tract symptoms (LUTS) in 106,435 middle-aged and older Australian men: population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Comparing effects of low- and high-volume moderate-intensity exercise on sexual function and testosterone in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Dietary macronutrients, cholesterol, and sodium and lower urinary tract symptoms in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Food groups and risk of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association of diet with prostate specific antigen and prostate volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Effects of bariatric surgery on untreated lower urinary tract symptoms: a prospective multicentre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

A prospective study of statin drug use and lower urinary tract symptoms in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Testosterone supplementation does not worsen lower urinary tract symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

A Population-based Survey of the Prevalence, Potential Risk Factors, and Symptom-specific Bother of Lower Urinary Tract Symptoms in Adult Chinese Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Global prevalence and economic burden of urgency urinary incontinence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Type 2 diabetes mellitus and risk of stress, urge and mixed urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Lower urinary tract symptoms in women with diabetes mellitus: a current review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Weight loss to treat urinary incontinence in overweight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Urinary Incontinence Before and After Bariatric Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the hospitalised and outpatients' profile and expectations study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association between metabolic syndrome and pelvic floor dysfunction in middle-aged to older Korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Effects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association of moderate to severe lower urinary tract symptoms with incident type 2 diabetes and heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Are lower urinary tract symptoms influenced by metabolic syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Association of metabolic syndrome with reduced central serotonergic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Physical activity and benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2015.301

The gut-adipose-liver axis in the metabolic syndrome

31 March 2020

1 reference

12 December 2020

Relationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study

1 reference

12 December 2020

Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility

1 reference

12 December 2020

The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms

1 reference

12 December 2020

Increased abdominal obesity in subjects with a mutation in the 5-HT(2A) receptor gene promoter

1 reference

12 December 2020

Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.

1 reference

12 December 2020

5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction

1 reference

12 December 2020

Hypogonadism and metabolic syndrome

1 reference

12 December 2020

Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2015.301

1 reference

Dimensions Publication ID

5 September 2017

0 references

1 reference